Literature DB >> 31088233

Quantification of PET infusion studies without true equilibrium: A tissue clearance correction.

Ansel T Hillmer1,2,3, Richard E Carson1,3,4.   

Abstract

In some positron emission tomography (PET) studies, a reversibly binding radioligand is administered as a constant infusion to establish true equilibrium for quantification. This approach reduces scanning time and simplifies data analysis, but assumes similar behavior of the radioligand in plasma across the study population to establish true equilibrium in all subjects. Bias in outcome measurements can result if this assumption is not met. This work developed and validated a correction that reduces bias in total distribution volume (VT) estimates when true equilibrium is not present. This correction, termed tissue clearance correction (TCC), took the form VT=VT(A)/(1+βγVT(A)), where β is the radioligand clearance rate in tissue, γ is a radiotracer-specific constant, and VT(A) is the apparent VT. Simulations characterized the robustness of TCC across imperfect values of γ and β and demonstrated reduction to false positive rates. This approach was validated with human infusion data for three radiotracers: [18F]FPEB, (-)-[18F]flubatine, and [11C]UCB-J. TCC reduced bias in VT estimates for all radiotracers and significantly reduced intersubject variance in VT for [18F]FPEB data in some brain regions. Thus, TCC improves quantification of data acquired from PET infusion studies.

Entities:  

Keywords:  Equilibrium; infusion; modeling; positron emission tomography; volume of distribution

Mesh:

Substances:

Year:  2019        PMID: 31088233      PMCID: PMC7168787          DOI: 10.1177/0271678X19850000

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  18 in total

1.  COMKAT: compartment model kinetic analysis tool.

Authors:  R F Muzic; S Cornelius
Journal:  J Nucl Med       Date:  2001-04       Impact factor: 10.057

2.  First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.

Authors:  Osama Sabri; Georg-Alexander Becker; Philipp M Meyer; Swen Hesse; Stephan Wilke; Susanne Graef; Marianne Patt; Julia Luthardt; Gudrun Wagenknecht; Alexander Hoepping; René Smits; Annegret Franke; Bernhard Sattler; Bernd Habermann; Petra Neuhaus; Steffen Fischer; Solveig Tiepolt; Winnie Deuther-Conrad; Henryk Barthel; Peter Schönknecht; Peter Brust
Journal:  Neuroimage       Date:  2015-05-30       Impact factor: 6.556

3.  Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography.

Authors:  R E Carson; M A Channing; R G Blasberg; B B Dunn; R M Cohen; K C Rice; P Herscovitch
Journal:  J Cereb Blood Flow Metab       Date:  1993-01       Impact factor: 6.200

4.  Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [18F]FP-DTBZ in Healthy Subjects and Patients with Type 1 Diabetes.

Authors:  Mika Naganawa; Keunpoong Lim; Nabeel B Nabulsi; Shu-Fei Lin; David Labaree; Jim Ropchan; Kevan C Herold; Yiyun Huang; Paul Harris; Masanori Ichise; Gary W Cline; Richard E Carson
Journal:  Mol Imaging Biol       Date:  2018-10       Impact factor: 3.488

5.  Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [(11)C]MADAM PET study.

Authors:  Sjoerd J Finnema; Christer Halldin; Benny Bang-Andersen; Christoffer Bundgaard; Lars Farde
Journal:  Psychopharmacology (Berl)       Date:  2015-05-17       Impact factor: 4.530

6.  Imaging synaptic density in the living human brain.

Authors:  Sjoerd J Finnema; Nabeel B Nabulsi; Tore Eid; Kamil Detyniecki; Shu-Fei Lin; Ming-Kai Chen; Roni Dhaher; David Matuskey; Evan Baum; Daniel Holden; Dennis D Spencer; Joël Mercier; Jonas Hannestad; Yiyun Huang; Richard E Carson
Journal:  Sci Transl Med       Date:  2016-07-20       Impact factor: 17.956

7.  18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry.

Authors:  Dean F Wong; Rikki Waterhouse; Hiroto Kuwabara; Jongho Kim; James R Brašić; Wichana Chamroonrat; Michael Stabins; Daniel P Holt; Robert F Dannals; Terence G Hamill; P David Mozley
Journal:  J Nucl Med       Date:  2013-02-12       Impact factor: 10.057

8.  Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies.

Authors:  Mark Slifstein; Raj Narendran; Dah-Ren Hwang; Yasuhiko Sudo; Peter S Talbot; Yiyun Huang; Marc Laruelle
Journal:  Synapse       Date:  2004-10       Impact factor: 2.562

9.  Feedback-controlled bolus plus infusion (FC-B/I) method for quantitative drug assessment in living brain with PET.

Authors:  Hiroyuki Ohba; Norihiro Harada; Shingo Nishiyama; Takeharu Kakiuchi; Yuichi Kimura; Hideo Tsukada
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-12       Impact factor: 6.200

10.  Dynamic image denoising for voxel-wise quantification with Statistical Parametric Mapping in molecular neuroimaging.

Authors:  Stergios Tsartsalis; Benjamin B Tournier; Christophe E Graf; Nathalie Ginovart; Vicente Ibáñez; Philippe Millet
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

View more
  2 in total

1.  Effect of age on brain metabotropic glutamate receptor subtype 5 measured with [18F]FPEB PET.

Authors:  Adam P Mecca; Kelly Rogers; Zachary Jacobs; Julia W McDonald; Hannah R Michalak; Nicole DellaGioia; Wenzhen Zhao; Ansel T Hillmer; Nabeel Nabulsi; Keunpoong Lim; Jim Ropchan; Yiyun Huang; David Matuskey; Irina Esterlis; Richard E Carson; Christopher H van Dyck
Journal:  Neuroimage       Date:  2021-05-27       Impact factor: 7.400

2.  Longitudinal imaging of metabotropic glutamate 5 receptors during early and extended alcohol abstinence.

Authors:  Ansel T Hillmer; Gustavo A Angarita; Irina Esterlis; Jon Mikael Anderson; Nabeel Nabulsi; Keunpoong Lim; Jim Ropchan; Richard E Carson; John H Krystal; Stephanie S O' Malley; Kelly P Cosgrove
Journal:  Neuropsychopharmacology       Date:  2020-09-12       Impact factor: 7.853

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.